Viela Bio
2017
FOUNDED
PUBLIC
STATUS
91-100
EMPLOYEES
VIE
STOCK SYMBOL
$26.15
SHARE PRICE
(As of Wednesday Closing)
Description
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- One MedImmune Way
- First Floor, Area Two
- Gaithersburg, MD 20878
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Viela Bio’s full profile, request a free trial.
Viela Bio Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $18.20 - $33.70 | $1.33B | $26.00 | $17.5M | 163K | 51M |
Viela Bio Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
|---|---|---|
| Revenue | 20,000 | 0 |
| EBITDA | (92,350) | (192,294) |
| Net Income | (89,913) | (190,270) |
| Total Assets | 233,840 | 139,827 |
| Total Debt | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Viela Bio Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Viela Bio‘s full profile, request access.
Request full access to PitchBookViela Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is reserved for PitchBook Platform users. To explore Viela Bio‘s full profile, request access.
Request full access to PitchBookViela Bio Competitors (18)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Apitope International | Venture Capital-Backed | Diepenbeek, Belgium | 0 | 000.00 | 00000000000 | 000.00 |
| 00000000 000000000 | Venture Capital-Backed | Boston, MA | 000 | 00.000 | 0000000000 0 | 00.000 |
| 000000000 00000000 | Venture Capital-Backed | San Diego, CA | 00 | 0000 | 00000000000 | 0000 |
| 0000000 | Venture Capital-Backed | Cambridge, MA | 000 | 00000000000 | 000 | |
| 0000000 000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 000000&0 | 00000 |
Viela Bio Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Viela Bio‘s full profile, request access.
Request full access to PitchBookViela Bio Executive Team (7)
2 Former Executives
You’re viewing 5 of 7 executives. Get the full list »Viela Bio Board Members (12)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andreas Wicki Ph.D | Self | Board Member | 000 0000 | |
| Edward Hu Ph.D | 6 Dimensions Capital | Board Member | 000 0000 | |
| Pascal Soriot | Self | Board Member | 000 0000 | |
| Sean Tong | Boyu Capital | Board Member | 000 0000 | |
| Tyrell Rivers Ph.D | Viela Bio | Board Member | 000 0000 |
4 Former Board Members
You’re viewing 5 of 12 board members. Get the full list »